Sleep Difficulties After Loss: Exploring the Beneficial Effect of Brief Behavioral Therapy for Insomnia in a Sample of Bereaved Individuals
SLEEPLOSS
Sleep Difficulties After Loss (SLEEPLOSS): Exploring the Beneficial Effect of Brief Behavioral Therapy for Insomnia in a Sample of Bereaved Individuals
1 other identifier
interventional
58
1 country
1
Brief Summary
The goal of the study is to investigate whether a brief behavioral therapy for insomnia (BBTI) improves sleep in bereaved patients screened for insomnia compared to an active control group (sleep hygiene education). The study will also explore if BBTI improves symptoms of complicated grief. The investigators will recruit approximately 58 bereaved participants with insomnia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2025
CompletedFirst Posted
Study publicly available on registry
September 11, 2025
CompletedStudy Start
First participant enrolled
December 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
November 17, 2025
August 1, 2025
1.4 years
September 4, 2025
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index (ISI)
The ISI measures the severity of insomnia symptoms and the associated impact on daytime functioning and distress. The questionnaire consists of 7 questions the sum of which makes up a total score. The ISI has a range of 0-28, with higher scores indicate worse insomnia severity.
Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).
Secondary Outcomes (14)
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).
Consensus Sleep Diary
Time Frame: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).
Morningness-Eveningness Questionnaire - Revised (MEQr)
Time Frame: Time Frame: Baseline (week 0)
Aarhus Prolonged Grief Disorder Scale (A-PGDs)
Time Frame: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).
Center for Epidemiological Studies Depression Scale - 10 Item Version (CESD-10)
Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).
- +9 more secondary outcomes
Study Arms (2)
Intervention group (group 1)
EXPERIMENTALParticipants will retrieve individually administered BBTI by therapists through face-to-face meetings and phone-calls. Treatment will take 4 weeks.
Active control group (group 2)
SHAM COMPARATORParticipants will receive access to sleep hygiene education (SHE) through written educational material. Treatment will take 4 weeks.
Interventions
BBTI is a multi-component intervention consisting of techniques from sleep restriction and stimulus control therapy. It targets behavioral elements of insomnia using four techniques: 1) reduce time in bed, 2) get up at the same time every day, 3) do not go to bed unless sleepy, and 4) do not stay in bed unless asleep.
SHE consists of education on lifestyle factors (diet, exercise, substance use) and enviromental variables (noise, light, temperature) affecting sleep quality.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Bereaved (experienced the death of a perceived loved one) ≥6 months ago
- Insomnia: a score of \>10 on the Insomnia Severity index (ISI) and/or meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for Insomnia Disorder
You may not qualify if:
- Other sleep disor-ders (sleep apnea, parasomnia, narcolepsy)
- Use of drugs impacting sleep
- Severe psychological or physical disorders that may confound sleep (symptoms of CGR allowed)
- Neurodegenerative disorders
- Shift work
- Insufficient Danish proficiency
- Previous experience with BBTI or cognitive behavioral therapy for insomnia (CBT-I)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University
Aarhus, Jutland, 8000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander D Castro-Pavlik, PhD-student, MSc in Psychology
University of Aarhus
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- We aim to mask the participants as much as possible. The study uses a single-blind randomized controlled design, in which participants will know what treatment they will receive and that there are two groups. However, they will not know what treatment the other group will receive or that one group is the intervention group and the other an active control group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2025
First Posted
September 11, 2025
Study Start
December 30, 2025
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2027
Last Updated
November 17, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 6 months after publication of the primary results and continuing for 5 years thereafter.
- Access Criteria
- Data will be made available to qualified researchers upon reasonable request to the study investigators, subject to approval and in accordance with applicable ethical and legal requirements.
De-identified individual participant data (e.g., outcome measure data underlying published analyses) will be shared.